As medical devices and diagnostics become ever more sophisticated and complex, companies are opting to launch new products in the US rather than Europe, according to an expansive study from UCLA Biodesign, the healthcare technology innovation hub at the University of California Los Angeles, and global management consulting firm Boston Consulting Group (BCG).
The March 2022
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?